Nephrolithiasis Clinical Trial
Official title:
Study of the Effects of DASH Style Diet and Oxalate Restricted Diet on Urinary Supersaturation Which is a Major Predisposing Factor for Nephrolithiasis
Oxalate restricted diet is routinely prescribed in clinical practice of nephrolithiasis
patients with hyperoxaluria. The effect of dietary oxalate on urinary oxalate is however
controversial. Some studies do not implicate dietary oxalate as a major risk factor for
nephrolithiasis. The Dietary Approaches to Stop Hypertension (DASH) diet, which is high in
fruits and vegetables, moderate in low-fat dairy products, and low in animal protein
represents a novel potential means of kidney stone prevention. The effect of a DASH-style
diet on relative urinary supersaturations is however uncertain. Higher consumption of fruits
and vegetables may increase urinary oxalate but also increases urinary citrate, an important
inhibitor of calcium saturation.All the above data lead us to hypothesize that a DASH diet
other than an oxalate restricted diet, which is routinely administered in clinical practice,
might be beneficial in lowering urinary relative supersaturations of calcium oxalate in
recurrent stone formers with hyperoxaluria.
Recurrent stone formers with hyperoxaluria (urine oxalate>32.8) are allocated into 2 groups.
The first group is prescribed an oxalate restricted diet. The second group are asked to
follow a calorie-controlled DASH diet plan while drink water in the same amounts. 24-h urine
is collected 2 times before study visits at baseline, 1 time on week 6 and 2 times at the end
of the study.
After a run-in period of 3 weeks patients are allocated into 2 groups. The first group is
prescribed an oxalate restricted diet. They are instructed to avoid oxalate-rich foods such
as spinach, rhubarb, beets, chocolate, cereals, nuts, tea, wheat bran, and strawberries and
to drink water in amounts of roughly 2 L during cold weather and 3 L during warm/hot weather.
The second group is asked to follow a calorie-controlled DASH diet plan. DASH is an eating
pattern recommended by the 2005 Department of Health and Human Services Dietary Guidelines
for Americans as a model of healthy eating for the majority of individuals in the population
. This group eats a diet which includes higher fruit, vegetables, and low-fat dairy products
and lower in saturated fat, total fat, and cholesterol, containing more whole grains and
fewer refined grains, sweets, and red meat. The calcium, potassium, and magnesium of the DASH
diet is higher. The DASH diet contains 2,400 mg Na per day . The servings, mentioned in the
publication of the National Institutes of Health regarding the DASH eating plan, are used as
a practical guideline. Lower consumption of meat and higher consumption of low-fat dairies,
vegetable, fruit, whole-grain cereals, and legumes distinguish between the DASH trial and the
weight-reduction diet.
We determine the caloric needs for each person in both groups individually according to the
Harris Benedict Formula:
Metric BMR Formula Women: BMR= 655 + ( 9.6 × weight in kilos ) + ( 1.8 × height in cm ) - (
4.7 × age in years ) Men: BMR= 66 + ( 13.7 × weight in kilos ) + ( 5 × height in cm ) - ( 6.8
× age in years )
To determine their total daily calorie needs, multiply their BMR by the appropriate activity
factor, as follows:
If they are sedentary (little or no exercise) : Calorie-Calculation = BMR × 1.2 If they are
lightly active (light exercise/sports 1-3 days/week) : Calorie-Calculation = BMR × 1.375 If
they are moderately active (moderate exercise/sports 3-5 days/week) : Calorie-Calculation =
BMR × 1.55 If they are very active (hard exercise/sports 6-7 days a week) :
Calorie-Calculation = BMR × 1.725 If they are extra active (very hard exercise/sports &
physical job or 2x training) : Calorie-Calculation = BMR × 1.9
The patients are visited in the beginning, after 6 weeks and at the end of the study; each
session for a patient is 45-60 min. They are in touch with the nutritionist by phone every
week. The nutritionist explains the benefits of each diet for patients and tells them if they
continue these diets, related metabolic abnormalities might be controlled. The diets are
individually prescribed using a calorie count system, and an exchange list is given to each
patient for exchanging food items and counting the calories. A nutritionist educates subjects
on how to use the exchange list. Patient compliance to diet is evaluated by a detailed food
recall for 3 days which are collected from 2 weekdays and 1 weekend day in week 1 and week 12
as well as evaluation of the urinary excretion of sodium, inorganic sulfate and total
nitrogen. The food recalls are reviewed by a nutrition PhD when they are submitted and then
are analyzed using nutritionist IV software. 24-h urine is also collected 2 times before
study visits at baseline, and 2 times at the end of the study on the day food recalls are
filled. Urinary supersaturation of calcium oxalate, calcium phosphate and uric acid also is
calculated at the beginning and end of the study. Because this is a dietary intervention,
patients are not blinded.
Clinical measurements included blood pressure, weight, height, and waist circumference. Blood
pressure measurements are the average of 2 measurements and are taken using an automated
system after the subjects are seated for 5 minutes. Participants are weighed wearing minimal
clothing and without shoes. Height is measured in a standing position, without shoes. Waist
circumference is measured where the waist is narrowest over light clothing. Body mass index
(kg/m2) is calculated as weight (kg) divided by height squared (m2) We use General Linear
Models (paired t tests) to globally compare means of all variables at the end of the 2
different diet periods with and without adjustment for weight. We calculate the percent
change for each variable using the formula (E- B/B)×100, where E was the end of treatment
value and B was the baseline value. Groups are compared using the percent change in the
General Linear Model (paired t test)analyses. We use ANCOVA to compare adjusted means of end
values and percent changes while weight change was included as a covariate. Results are
considered significant if the 2-tailed P-value is<,0.05. Statistical analyses are performed
using STATA 15.0.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT03692715 -
Antibiotic Prophylaxis Before Shock Wave Lithotripsy
|
Phase 4 | |
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02289755 -
Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
|
Phase 2 | |
Completed |
NCT01690039 -
Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis
|
||
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Recruiting |
NCT05014178 -
Kidney Sodium Functional Imaging
|
||
Not yet recruiting |
NCT06199102 -
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
|
N/A | |
Recruiting |
NCT04367155 -
Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.
|
N/A | |
Recruiting |
NCT04374188 -
Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Recruiting |
NCT04389853 -
Mini-PNCL vs fURS in Management of Nephrolithiasis
|
N/A | |
Completed |
NCT03348228 -
Effect of Hydroxycitrate on Urine Chemistry
|
N/A | |
Completed |
NCT05350423 -
Trial Assessing Renal Damage During Ureteroscopy
|
N/A | |
Completed |
NCT03454139 -
Subcostal TAP Block For Percutaneous Nephrolithotomy
|
N/A | |
Recruiting |
NCT02279927 -
Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy
|
N/A | |
Completed |
NCT02276924 -
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
|
N/A | |
Completed |
NCT00159393 -
Percutaneous Nephrolithotomy: A Registry and Database
|
||
Completed |
NCT02878148 -
Conditional Imaging Prescription Strategy for Exploration of Acute Uncomplicated Renal Colic
|
N/A |